Search results
Intercept's (ICPT) NDA for NASH Treatment Accepted By FDA
Zacks via Yahoo Finance· 1 year agoIntercept's (ICPT) new drug application (NDA) for obeticholic acid (OCA) for the treatment of...
Intercept (ICPT) Reports Positive Data From NASH Study on OCA
Zacks via Yahoo Finance· 2 years agoIntercept (ICPT) reports positive top-line results from a new analysis of its ongoing pivotal phase...
Intercept Tumbles As Its Experimental NASH Drug Faces Yet Another Obstacle
Investor's Business Daily· 1 year agoIntercept Pharmaceuticals said Friday its experimental liver disease treatment will face a Food and...
Intercept Crashes As FDA Advisors Deliver The Likely Deathblow For Its Highly Watched NASH Drug
Investor's Business Daily· 1 year agoThe Food and Drug Administration will likely reject Intercept Pharmaceuticals' highly watched liver...
Intercept Pharmaceuticals (ICPT) Surges on Acquisition Deal
Zacks via Yahoo Finance· 9 months agoShares of Intercept Pharmaceuticals, Inc. ICPT soared 79.2% after Italy-based pharmaceutical company...
Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) Q4 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoIntercept Pharmaceuticals, Inc. (NASDAQ:ICPT) Q4 2022 Earnings Call Transcript March 2, 2023...
Intercept Pharmaceuticals Crashes After Drug Fails In Cirrhotic Patients
Investor's Business Daily· 2 years agoIntercept Pharmaceuticals' experimental NASH treatment failed in patients with liver cirrhosis,...
Intercept (ICPT) Earnings Miss, Sales Top Estimates in Q2 (Revised)
Zacks via Yahoo Finance· 2 years agoIntercept Pharmaceuticals, Inc. (ICPT) incurred a loss of 68 cents per share (from continuing...
Why Intercept Pharmaceuticals Stock Is Soaring Today
Motley Fool· 2 years agoShares of Intercept Pharmaceuticals (NASDAQ: ICPT) were soaring 15.7% higher as of 12:02 p.m. ET on Tuesday. It also easily topped the average analysts'...
Intercept Pharma Stock Tumbles: FDA Panel Votes Against Intercept's Fatty Liver Drug, Dashing Its...
Benzinga via Yahoo Finance· 1 year agoFDA's Gastrointestinal Drugs Advisory Committee voted 12 to 2—with two abstentions—that the benefits...